Association of alkaline phosphatase (ALP) with clinical outcomes in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302.

Citation

• Yu, E. Y., Saad, F., Londhe, A., Shore, N. D., Van Poppel, H., Rathkopf, D. E., . . . Ryan, C. J. (2014). Association of alkaline phosphatase (ALP) with clinical outcomes in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302.. Journal of Clinical Oncology, 32(4_suppl), 27. doi:10.1200/jco.2014.32.4_suppl.27

Digital Object Identifier (doi)

• 10.1200/jco.2014.32.4_suppl.27

Web Of Science Accession Number

Start Page

• 27

End Page

• 27

Volume

• 32

Issue

• 4_suppl

Place Of Publication

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2014

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Yu, E. Y., Saad, F., Londhe, A., Shore, N. D., Van Poppel, H., Rathkopf, D. E., . . . Ryan, C. J. (2014). Association of alkaline phosphatase (ALP) with clinical outcomes in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302.. Journal of Clinical Oncology, 32(4_suppl), 27. doi:10.1200/jco.2014.32.4_suppl.27

Digital Object Identifier (doi)

• 10.1200/jco.2014.32.4_suppl.27

Web Of Science Accession Number

Start Page

• 27

End Page

• 27

Volume

• 32

Issue

• 4_suppl

Place Of Publication